This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
PEACE-3 Trial
PROfound Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
ADSTILADRIN
ANKTIVA
Bladder Cancer Detection
CORE-001 Study
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Trials in Progress
Trials in Progress
Bladder Cancer
BOND-003 Cohort P
CORE-008
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SUO 2024
SCS AUA 2024
ASTRO 2024
IBCN 2024
ESMO 2024
All Conferences
View All
Quick Takes
ESMO 2024
PCF
UroToday Home
Recent Abstracts
Urologic Oncology
Prostate Cancer
Recent Abstracts
A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer - Abstract
July 18, 2013
There are calls for a national screening programme for prostate cancer: What is the evidence to justify such a national screening programme? - Abstract
July 18, 2013
Do hormone treatments for prostate cancer cause anxiety and depression? - Abstract
July 18, 2013
The experiences of gay and bisexual men diagnosed with prostate cancer: Results from an online focus group - Abstract
July 18, 2013
New developments in the management of prostate cancer - Abstract
July 18, 2013
Changes in indications and oncological outcomes of radical prostatectomy after 2000--Data from 1268 Japanese patients treated with radical prostatectomy between 2000 and 2009 - Abstract
July 18, 2013
Urologists respond to new report disparaging specialists, in-office pathology labs
July 17, 2013
Risk assessment to guide prostate cancer screening decisions: A cost-effectiveness analysis - Abstract
July 17, 2013
Population-based study of utilization and determinants of active surveillance and watchful waiting for low- and intermediate-risk prostate cancer - Abstract
July 17, 2013
Utility of multiparametric MRI suspicion levels in detecting prostate cancer - Abstract
July 17, 2013
Advances in the treatment of metastatic prostate cancer - Abstract
July 17, 2013
Retraction of external iliac vessels and obturator nerve with the vas deferens during extended pelvic lymph node dissection in robot-assisted radical prostatectomy - Abstract
July 17, 2013
Interactions between lower urinary tract symptoms and cardiovascular risk factors determine distinct patterns of erectile dysfunction: A latent class analysis - Abstract
July 17, 2013
Patterns of care for men diagnosed with prostate cancer in Victoria from 2008 to 2011 - Abstract
July 17, 2013
A fully automated method for CT-on-rails-guided online adaptive planning for prostate cancer intensity modulated radiation therapy - Abstract
July 17, 2013
Population-based validation of a policy change to use long-term androgen deprivation therapy for cT3-4 prostate cancer: Impact of the EORTC22863 and RTOG 85-31 and 92-02 trials - Abstract
July 17, 2013
Does hormone therapy modify the position of the gold markers in the prostate during irradiation? A daily evaluation with kV-images - Abstract
July 17, 2013
Morbidity after transperineal prostate biopsy in 3000 patients undergoing 12 vs 18 vs more than 24 needle cores - Abstract
July 17, 2013
Tumor lesion diameter on diffusion weighted magnetic resonance imaging could help predict insignificant prostate cancer in patients eligible for active surveillance: Preliminary analysis - Abstract
July 16, 2013
Adenocarcinoma of the prostate with Gleason score 9-10 on core biopsy: Correlation with findings at radical prostatectomy and prognosis - Abstract
July 16, 2013
Page 1149 of 1447
Start
Prev
1144
1145
1146
1147
1148
1149
1150
1151
1152
1153
Next
End
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free